Related Experiment Videos
Binding of platelet factor four (PF 4) to glomerular polyanion
Kidney International
|May 1, 1984
Summary
Human platelet factor 4 (PF 4) binds to glomerular polyanion (GPA), acting like a polycation. This binding, particularly in the glomerular basement membrane, suggests PF 4 may influence glomerular permeability and kidney disease.
Area of Science:
- Nephrology
- Biochemistry
- Cell Biology
Background:
- Synthetic polycations can increase glomerular permeability by binding to glomerular polyanion (GPA).
- Human platelet factor 4 (PF 4) is a platelet secretory protein with potential roles in kidney function.
Purpose of the Study:
- To investigate the binding of human platelet factor 4 (PF 4) to glomerular polyanion (GPA).
- To determine the mechanism and location of PF 4 binding to glomerular structures.
- To assess the potential role of PF 4 in glomerular permeability and disease.
Main Methods:
- Immunofluorescence and immunoperoxidase techniques on human and rat renal cortex sections.
- Isotopic binding studies using 125I-PF 4 with isolated glomerular basement membrane (GBM) suspensions.
- Ex vivo perfusion of rat kidneys with PF 4 followed by electron microscopy (EM).
Main Results:
- PF 4 demonstrated dose-dependent, saturable binding to the GBM, reversible by heparin.
- PF 4 localized to the mesangium and capillary walls, with EM revealing binding sites within the GBM laminae rarae.
- Ionic interactions were confirmed by NaCl and heparin washing, and polycation pretreatment blocked PF 4 binding.
Conclusions:
- Human platelet factor 4 (PF 4) exhibits polycation-like properties by binding to glomerular polyanion (GPA).
- PF 4 binding occurs within the glomerular basement membrane and on cell surfaces.
- PF 4's interaction with GPA suggests a potential role in altering glomerular permeability and contributing to glomerular diseases.